The disease was less likely to recur in young women who had mastectomy plus radiation than in young women who had mastectomy alone or breast conserving therapy.
Scientists say the data supports consideration of chemotherapy for all patients.
The study appears in the International Journal of Radiation Oncology, Biology and Physics.